AFP – A US-based patient rights group said Saturday it has sought to block a bid by California-based Gilead Sciences to obtain an Indian patent for a potentially blockbuster drug to treat hepatitis C. New York’s Initiative for Medicines, Access & Knowledge (I-MAK), which works to...
![]()
![]()
![]()
![]()
![]()
↧